PER1
PER1 is a gene that encodes the protein Period circadian regulator 1 in humans. It is one of the core components of the circadian clock, which governs the timing of various physiological processes, including sleep, metabolism, and hormone regulation. PER1 is involved in the generation and maintenance of circadian rhythms, playing a crucial role in the feedback loop that drives cellular timekeeping.
Function[edit | edit source]
PER1 is part of a family of period genes, which also includes PER2 and PER3. These genes produce proteins that are integral to the circadian clock. PER1 protein interacts with other core clock proteins such as CRY1 (cryptochrome circadian regulator 1) and CRY2, to regulate the circadian rhythms. The PER1 protein, along with its homologs, negatively regulates the activity of the CLOCK-BMAL1 transcription factor complex, thus controlling the transcription of various genes that are involved in the circadian cycle.
Genetic Structure[edit | edit source]
The PER1 gene is located on chromosome 17 (17p13.1) in humans. It consists of multiple exons and introns that span more than 129,000 base pairs. The gene undergoes complex alternative splicing, which results in multiple transcript variants encoding different isoforms of the PER1 protein.
Clinical Significance[edit | edit source]
Alterations in the expression or function of PER1 have been linked to various sleep disorders, including familial advanced sleep phase syndrome and delayed sleep phase disorder. Additionally, because of its role in regulating the timing of cellular processes, PER1 is also implicated in the study of chronotherapy and its effectiveness in treating certain diseases. There is growing evidence suggesting that disruptions in circadian rhythms, potentially through mutations or misregulation of circadian genes like PER1, may be linked to increased susceptibility to cancer, metabolic syndrome, and cardiovascular diseases.
Research[edit | edit source]
Research on PER1 continues to uncover its complex role in circadian regulation and its broader implications in health and disease. Studies have explored its potential as a target for therapeutic interventions in sleep disorders, cancer, and other diseases where circadian disruption is a factor.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD